Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome

Background and Aims Obstructive sleep apnea syndrome (OSA) is an independent risk factor for endothelial dysfunction and cardiometabolic diseases. Plasma endocan levels are elevated in a large number of diseases, and is a novel surrogate endothelial cell dysfunction marker. We aimed to assess the ro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The clinical respiratory journal 2018-01, Vol.12 (1), p.84-90
Hauptverfasser:	Kanbay, Asiye, Ceylan, Erkan, Köseoğlu, Handan İnönü, Çalışkan, Mustafa, Takir, Mumtaz, Tulu, Selcan, Telci Çaklılı, Ozge, Köstek, Osman, Erek, Aybala, Afsar, Baris
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - blood Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Cardiovascular Diseases - physiopathology Cross-Sectional Studies endocan endothelial dysfunction Endothelium, Vascular - physiopathology Female Follow-Up Studies Humans Male Middle Aged Neoplasm Proteins - blood obstructive sleep apnea Polysomnography Prognosis Proteoglycans - blood Risk Factors Sleep apnea Sleep Apnea, Obstructive - blood Sleep Apnea, Obstructive - complications Sleep Apnea, Obstructive - physiopathology Vasodilation - physiology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!